AOC3 and stage 5 chronic kidney disease: Serum VAP-1 levels are higher in patients with T2DM and in patients with chronic kidney disease, which makes serum VAP-1, a good predictor of end-stage renal disease in diabetic patients and a useful biomarker to improve risk stratification of patients with T2DM (Li et al., 2016).